Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 69.01M P/E - EPS this Y -129.00% Ern Qtrly Grth -
Income -7.02M Forward P/E -28.86 EPS next Y 252.10% 50D Avg Chg -16.00%
Sales 10.96M PEG - EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book 2.31 EPS next 5Y - 52W High Chg -57.00%
Recommedations 2.00 Quick Ratio 8.33 Shares Outstanding 11.45M 52W Low Chg 42.00%
Insider Own 10.16% ROA -13.06% Shares Float 7.82M Beta 0.41
Inst Own 12.23% ROE -23.16% Shares Shorted/Prior 8.89K/8.11K Price 6.06
Gross Margin 81.83% Profit Margin -64.05% Avg. Volume 14,238 Target Price 11.00
Oper. Margin -1,694.98% Earnings Date May 22 Volume 1,366 Change -2.57%
About CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

CollPlant Biotechnologies Ltd. News
04/23/24 CollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its Business
04/04/24 COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
03/26/24 COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
03/13/24 Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years ago
02/15/24 CollPlant Issues Letter to Shareholders
01/08/24 CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
01/02/24 CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
11/29/23 CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
11/09/23 COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
05:10 AM Will CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely?
11/01/23 CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
09/21/23 CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
09/05/23 CollPlant to Present at the H.C. Wainwright Annual Growth Conference
08/27/23 Results: CollPlant Biotechnologies Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
08/24/23 CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
08/09/23 COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
06/26/23 CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
05/24/23 CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
CLGN Chatroom

User Image mikesterz7 Posted - 04/04/24

$CLGN Dermal filler program with AbbVie in clinical phase Regenerative breast implant program large-animal study underway to evaluate commercial-size implants with topline data expected in Q4 Ends 2023 with $26.7 million in cash and cash equivalents

User Image DH_Explorer Posted - 04/04/24

$GRRR Hold GRRR, Hold $RELI or buy at $0.51, think about getting into $CLGN

User Image DH_Explorer Posted - 04/04/24

$CLGN This alone should cause this stock to, pardon the pun, GROW SIZABLY! "Currently, there are no commercial products that allow regeneration of soft tissues such as the breast...CollPlant's proprietary plant-derived rhCollagen and other biomaterials, are expected to regenerate breast tissue without eliciting immune response, and therefore may provide a revolutionary alternative for aesthetic and reconstructive procedures....In addition, CollPlant's regenerative breast implants can be a novel solution for women in the breast reconstruction and augmentation market, which is sizeable, as it is the second most common plastic surgery procedure that is performed worldwide today." https://finance.yahoo.com/news/collplant-biotechnologies-reports-2023-full-110000410.html

User Image epsguid Posted - 04/04/24

$CLGN reported a loss of $0.42 via @eWhispers http://eps.sh/d/clgn

User Image Stock_Titan Posted - 04/04/24

$CLGN COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-reports-2023-full-year-financial-results-4nugj4vbn16a.html

User Image Stock_Titan Posted - 03/26/24

$CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-announces-date-for-2023-full-year-wb5hgzpetm2q.html

User Image EBE_Day Posted - 03/19/24

$CLGN 👀🤞🍀

User Image _StockTrader Posted - 03/07/24

Real-Time Stock Data $CLGN Price: 5.2 Volume: 9130 Market Cap: 59554036 PE Ratio: -7.428571 Powered by: SKYX

User Image EBE_Day Posted - 2 months ago

$SSYS $CLGN watch out for this colab totake off - "In April of last year, we announced a joint development and commercialization agreement with Stratasys Ltd. to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys' P3 technology-based bioprinter and CollPlant's rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants program. The new bioprinter, based on Stratasys' precise P3™ 3D printing technology in combination with CollPlant's flagship bioinks, is designed to enable the production of CollPlant's state of the art breast implants, which are being developed to regenerate an individual's natural breast tissue without eliciting immune response, providing a potentially revolutionary alternative for both aesthetic and reconstructive procedures."

User Image TheTradeXchange Posted - 02/15/24

$CLGN - CollPlant Issues Letter to Shareholders

User Image Stock_Titan Posted - 02/15/24

$CLGN CollPlant Issues Letter to Shareholders https://www.stocktitan.net/news/CLGN/coll-plant-issues-letter-to-ygfjjb1bf9ne.html

User Image NicholasRamsbotham Posted - 02/04/24

$IBKR $PINS $CLGN Analyst price target for next week. https://live-alerts-stock-trades.topmarketwatch.vip

User Image AndrewMargolin Posted - 3 months ago

$CLGN $PINS $IBKR Analyst price target for today: https://live-alerts-stock-trades.topmarketwatch.vip

User Image MatthewRechner Posted - 01/31/24

$CLGN $PGRU $AE Analyst price target for next week;. https://main-stock-trading-chatplatform.topmarketwatch.vip

User Image tickeron Posted - 01/12/24

What do you think of this? $CLGN MACD Histogram turned negative on January 11, 2024. View odds of downtrend. https://srnk.us/go/4967140

User Image EBE_Day Posted - 01/09/24

$CLGN

User Image ChartMill Posted - 01/08/24

$CLGN: CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California https://www.chartmill.com/stock/quote/CLGN/news?utm_source=prnews-2024-1-8-collplants-ceo-to-present-at-the-octane-aesthetic-tech-forum-conference-in-newport-beach-california&utm_medium=stocktwits&utm_campaign=pressRelease

User Image Stock_Titan Posted - 01/08/24

$CLGN CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California https://www.stocktitan.net/news/CLGN/coll-plant-s-ceo-to-present-at-the-octane-aesthetic-tech-forum-j9ht49z351uk.html

User Image DonCorleone77 Posted - 4 months ago

$CLGN CollPlant begins trial of commercial-size, regenerative breast implants CollPlant Biotechnologies announced its initiation of a pre-clinical trial to evaluate commercial-size, 3D-bioprinted, regenerative breast implants. Currently, there are no commercial products that allow regeneration of soft tissues such as the breast. "We are very happy with the progress of our regenerative breast implants program thus far, and the initiation of this important study," said CollPlant's CEO, Yehiel Tal. "CollPlant's breast implants in development are unique in that they are designed to regenerate breast tissue as well as have inherent safety advantages. This would be paradigm-shifting in a market that has maintained such a large demand yet has seen increasing issues with safety over the last few decades. A primary goal of this study is to obtain data which would then support the optimization of the implant design and apply this design to a pivotal large-animal study...."

User Image risenhoover Posted - 4 months ago

$CLGN / CollPlant Biotechnologies files form 6-K https://fintel.io/doc/sec-collplant-biotechnologies-ltd-1631487-6k-2024-january-02-19724-9460?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Stock_Titan Posted - 4 months ago

$CLGN CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants https://www.stocktitan.net/news/CLGN/coll-plant-biotechnologies-begins-preclinical-trial-with-commercial-j4utwnvg2p4y.html

User Image tickeron Posted - 4 months ago

A.I.dvisor made a bullish call on $CLGN, netting in a 26.69% gain over 2 weeks https://srnk.us/go/4956877

User Image ChartMill Posted - 12/31/23

$CLGN did better than 52% of all stocks in the Biotechnology industry. https://www.chartmill.com/stock/quote/CLGN/technical-analysis?key=6de53c7e-ae96-4dc8-85d0-19b98d8e71ee&utm_source=TA&utm_medium=stocktwits&utm_campaign=TA&utm_content=CLGN

User Image StockAutomatePro Posted - 12/30/23

$CLGN Not a bad time to invest in this stock chart is showing promising growth. We alerted the BUY signal at $5.27 and we were able to close this one with profit at $6.39🤙 See more details at StockAutomate.com

User Image StockAutomatePro Posted - 12/28/23

$CLGN Chart analysis suggests a bright future for the stock. We alerted the BUY signal at $5.36 and we were able to close this one with profit at $6.55 ✅ See more details at StockAutomate.com

User Image Stocks4thought Posted - 12/27/23

$CLGN Nice products- how far from market is lead product?

User Image dividendinvestorbyeagle Posted - 12/27/23

$CLGN close increased > 10% (Ord (New)/CollPlant Biotechnologies Ltd) https://www.dividendinvestor.com/dividend-news/?symbol=clgn http://dlvr.it/T0fNcd

User Image StockAutomatePro Posted - 12/26/23

$CLGN The chart is indicating an upward trajectory for the stock price We alerted the BUY signal at $5.18 and we were able to close this one with profit at $6.215 💖

User Image Nastram Posted - 12/19/23

$CLGN ..pbla running premarket on cancer news

User Image tickeron Posted - 12/11/23

A.I.dvisor is predicting $CLGN is about to move higher. View odds of uptrend. https://srnk.us/go/4938164

Analyst Ratings
HC Wainwright & Co. Buy Apr 5, 24
HC Wainwright & Co. Buy Nov 30, 23
HC Wainwright & Co. Buy Aug 25, 23
HC Wainwright & Co. Buy Mar 30, 23
Alliance Global Partners Buy Feb 17, 23